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     This thesis presents a mathematical model to reproduce hemodynamic responses 
of different endpoints to the blood volume perturbation in circulation system. The 
proposed model includes three sub-models, which are a control-theoretic model relating 
blood volume response to blood volume perturbation, a physiologic-based model 
relating cardiac output response to blood volume perturbation, and a control-theoretic 
model relating mean arterial pressure response to cardiac output perturbation. Two 
unique characteristics of this hemodynamic model are that the model can reproduce 
responses accurately even with its simplicity, and can be easily understood by control 
engineers because of its physiological transparency. With these two advantages, closed-
loop resuscitation controller evaluation can be performed in model-based approach 
instead of evaluating results from animal studies, which are relatively costly and time-
consuming. In this thesis, the hemodynamic model was examined and evaluated by 
using experimental dataset collected from 11 animals. The results of system 
identification analysis, in-silico evaluation and parametric sensitivity analysis showed 
 
 
that the hemodynamic model may faithfully serve as a evaluation basis for the closed-
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Chapter 1: Introduction 
 
1.1 Fluid Resuscitation 
Intravenous fluid regulation has become a regular part of circulatory resuscitation 
in healthcare in decades since it keeps circulatory system within normal state while 
patients suffering from hypovolemia caused by trauma or infection. In today’s clinical 
practice, most fluid resuscitation works are conducted by medical personnel or 
caretakers in a titration way. This continuous and heavy-workload task reveals some 
limitation and challenges and causes the desire of the autonomous systems in fluid 
resuscitation based on some reasons. First, the autonomous systems can optimize 
amounts of titration by acquiring information from different target end-points of 
patients, such as blood pressure, heart rate or urine output. With the optimal titration 
rate, the error and failure of the fluid regulation therapy can be reduced and stabilized. 
Second, autonomous infusion has better robustness than caretakers because it can deal 
with variabilities in physiological responses across different patients and different 
stages of trauma. Third, by maintaining long-term therapy with less error adjustments, 
the implementation of autonomous resuscitation systems can efficiently alleviate the 
workload of medical personnel and reduce the cost in medical treatments. 
 
1.2 Autonomous Resuscitation System 
Although autonomous closed-loop resuscitation systems have been studied for 
years, however, existing works in terms of controller design or model evaluation are 
still limited. Most closed-loop fluid resuscitation controllers in recent study are 
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designed and evaluated based on the naive decision-tree rules or simple controller gain 
tuning [1-4], which is lack of robustness and requires model-based design and 
approaches in the control-theory aspect to improve the autonomous resuscitation 
systems [5-9]. Besides, most autonomous resuscitation systems are evaluated by results 
of large-scale animal experiments [10-12], which are costly and time-consuming. Thus, 
for the time- and cost- efficient computation purpose, a credible system-level 
mathematical model that can efficiently capture the key phenomenon in circulation 
system and reproduce hemodynamic response to infusion or perturbation in non-
clinical testing is beneficial to the field of evaluation and design autonomous 
resuscitation controller. 
However, existing mathematical models for the purpose of reproducing 
hemodynamic response to perturbation of blood volume still have some limitations and 
do not fulfilled requirements discussed above. One class of existing black-box models 
can allow multiple infusions of various fluids to be specified and includes an estimation 
of the volumes, but they are too empiric to offer viable physical implications for clinical 
using [13-16]. Another class of existing models is first-principle model that 
comprehends all physiological phenomenon in human body. Because this kind of model 
involves hundreds parameters, it is too complex for computation and the purpose of 
closed-loop controller design [17-22]. Therefore, in order to address these challenges 
and limitations, the priority for the development of next generation closed-loop fluid 
resuscitation controller is constructing a simple and accurate mathematical model that 
suits for controller design and evaluation. For example, a model is able to reproduce 
hemodynamic responses, such as blood volume (BV), stroke volume (SV), cardiac 
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output (CO) and mean arterial pressure (MAP), to blood volume perturbation can be 
used as clinical endpoints in today’s fluid resuscitation practice. 
 
1.3 Thesis Goals and Outline 
This thesis presents a lumped-parameter model to reproduce hemodynamic 
response to hemorrhage and fluid infusion that is able to apply to closed-loop fluid 
resuscitation controller evaluation. This model consist three different sub-models in 
different stages, including BV, CO and MAP sub-models, which are established in the 
fields of control theory and physiology, or developed base on our prior works [23]. 
Compare to existing hemodynamic models, the proposed model is unique based on two 
key characteristics. One of the characteristics is its simplicity, which only involves 
eleven parameters and is beneficial for establishing system-level feedback control 
action in autonomous systems. The other characteristic is its physiological transparency, 
which can be easily understood with control-mechanism system instead of using 
established physiological knowledge. In addition, the proposed model was examined 
by using animal experimental data collected from eleven sheep for its validity. 
The thesis is organized as follows. In Chapter 2, a fully individualized 
hemodynamic model with three sub-models was studied and developed. In Chapter 3, 
we will apply this mathematical model to an experimental dataset collected from eleven 
sheep and perform system identification and sensitivity analysis and pick up some 
population-average candidate model for the further controller testing. In Chapter 4, we 
will apply the same control scheme using in the same animal experiment to the 
hemodynamic model and evaluate its validity through in-silico testing. In Chapter 5, 
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Chapter 2: Model to Reproduce Hemodynamic Responses 
 
2.1 Overview 
As shown in Figure 2.1, The structure of the hemodynamic model in this thesis 
consists three sub-models which are able to reproduce three different responses 
individually, including (a) a control-theoretic blood volume (BV) model related to the 
perturbation such as fluid infusion or hemorrhage; (b) a physiologic-based cardiac 
output (CO) model to the perturbation of BV; (c) a control-theoretic mean arterial 
pressure (MAP) model related to the perturbation of CO. 
In this chapter, we will introduce the structure of these three different sub-models, 
(a-c), in the hemodynamic model separately. After the structure of these three sub-
models are well established, then we will also present how we combine them and 
























2.2 Three Sub-models 
2.2.1 Modeling of Blood Volume Response to Blood Volume Perturbation 
From the study in physiology, there are two major compartments contain the fluid 
in the human body, which are extracellular fluid (including plasma and interstitial fluid) 
and intracellular fluid (fluid contained in cells) [24]. In the observation of clinical 
practice, large-scale blood volume perturbation such as fluid infusion or hemorrhage 
occurs primary variation of fluid volume in the intravascular (plasma) compartment and 
interstitial fluid (ISF) compartment. However, due to the extracellular compartment is 
able to dynamically distribute fluid in plasma and ISF compartments via inter-
compartmental shift, the fluid contained in two compartments can be regulated within 
specific range of ratio [24]. In our previous work, a model of BV response base on the 
feedback control theory and the knowledge of inter-compartmental fluid shift was 
developed [23]. The feedback control mechanism in this model was established base 
on the physiological principles of fluid distribution, which indicates that the volumetric 
change in the intravascular compartment is distributed to the plasma and the ISF with 
a certain ratio [24]. Based on this principle, the abstracting and complex inter-
compartmental shift phenomenon can be simplified as a feedback control system with 
a simple compensator. 
The fluid distribution ratio mentioned above varies depending on the 
physiological state of subject, which is determined by the vessel permeability, and 
hydraulic and osmotic pressure gradients at the capillary wall. However, from 
macroscopic standpoint, the consequence of the interaction among these complex 
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mechanisms is that the ratio between the volume changes in plasma and ISF can be 
summarized by a simple parameter value, denote here as 𝛼 . Typically, ISF volume 
changes 2-3 times as much as plasma volume changes (i.e., 𝛼 = 2-3). As shown in 
Figure 2.2, if blood volume is in the normal condition and does not beyond the critical 
blood volume, the relationship between the volumetric change of plasma and ISF can 
be consider as linear, which also means that 𝛼 can be consider as a constant value. 
However, due to the composition in the fluids involved in infusion and hemorrhage 
processes are different (while the blood lost consists of plasma and red blood cells, the 
fluid infusion consist of crystalloid, such as Lactated Ringer’s solution, or colloid, such 
as Hextend), the fluid distribution ratio in the steady state in response to fluid gain (fluid 
infusion) and fluid loss (hemorrhage and urine) are defined separately as two different 
constant value, which denote here as 𝛼𝑢 (gain) and 𝛼𝑣 (loss) respectively. Based on 
the principle of fluid shift, the desire steady-state change in plasma compartment, 













             (2.1) 
where 𝑢 is the fluid infusion rate and 𝑣 are the fluid loss rate, including hemorrhage 
and urine. With the value 𝑟𝐵𝑉(𝑡) calculated from the Equation (2.1), the rate of inter-
compartmental fluid shift (from plasma to ISF), 𝑞(𝑡), between the two compartments 
is determined by the discrepancy, 𝑒𝐵𝑉(𝑡), between desire steady-state value, 𝑟𝐵𝑉(𝑡), 
and actual BV volumetric change (plasma), Δ𝑉𝐵, and can be written as follows: 































a ↑ as Blood Volume ↑
 
Fig. 2.2. Relationship between blood volume and interstitial fluid volume. 
After the rate of fluid shift is calculated and apply to the intravascular 
compartment, the rate of change in Δ𝑉𝐵 at time 𝑡 can be determined due to the 
conservation of fluid volume, which is equal to the summation of fluid gain (𝑢(𝑡)), 
fluid loss (𝑣(𝑡)), and outflow fluid shift (𝑞(𝑡)): 
Δ𝑉𝐵̇ (𝑡) = 𝑢(𝑡) − 𝑣(𝑡) − 𝑞(𝑡)                  (2.3) 
For the fluid shift (𝑞(𝑡)), there is a simple proportional (P) controller control the 
rate and the direction (inflow or outflow) of the fluid shift, which strives the error 
between desired value and actual value of blood volume close to zero in steady state. 
Thus, the shift value in Equation (2.2) can be derived as follows: 
𝑞(𝑡) = −𝐾𝑝(𝑟𝐵𝑉(𝑡) − Δ𝑉𝐵(𝑡))                 (2.4) 
where 𝐾𝑝 is the proportional gain of the fluid shift controller, and the negative sign 
before 𝐾𝑝  represents the outflow direction in intravascular compartment. By 
combining the Equation (2.1) – (2.4), the governing equation of fluid shift dynamics 
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can be written as follows: 






𝑣(𝑡)    (2.5) 
As shown in Figure2.3, the structure of the BV sub-model can be visualized as a 
two-tank system connected with a fluid flow valve, where the two tanks represent 
plasma compartment and ISF compartment, and the valve represent the control 
































Fig. 2.3. A sketch of the blood volume sub-model. 
 
2.2.2 Modeling of Cardiac Output Response to Blood Volume Changes 
Because of the blood volume in intravascular compartment change, the cardiac 
output is also changed consequently at the vascular and ventricular standpoints. From 
the Arthur Guyton’s previous work, he and his coworkers proposed a theory about 
venous-return (VR) system based on observations that as cardiac output (CO), which 
rate is similar to VR in steady state, was experimentally increased the right atrial 
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pressure decreased. The results illustrated that a volumetric perturbation in blood 
volume (BV) occurs variations in CO and VR, and their rate can be altered by the 
difference between mean systemic pressure (MSP) and central venous pressure (CVP) 
as follows [25]: 






          (2.6) 
where 𝑃𝑀𝑆(𝑡) is MSP, 𝑃𝐶𝑉(𝑡) is CVP, and 𝑅𝑉𝑅 is a hypothetical resistance to VR, 
which value is related to the elasticity and the muscle tissue of the venous return vessels, 
and it is proportional to the total peripheral resistance (TPR) in circulation system, 








                (2.7) 
where 𝑉𝐵𝑈 is unstressed BV, which is proportional to the normal state value or initial 
value of BV (before applying infusion or hemorrhage profile), and it denotes as the 
product of 𝜂 and 𝑉𝐵0 . 𝐶𝑠 is also a hypothetical term that represents the systemic 
capacitance in circulation system [26]. By applying the Equation (2.7) to the Equation 
(2.6), the relationship of BV, CO, heart rate (HR) and stroke volume (SV) can be written 
as follows: 
















        (2.8) 
Furthermore, with the Frank-Starling Mechanism and the left ventricular (LV) 
pressure-volume loop relationship [27], the perturbation in SV and CO is occurred by 






(𝑉𝑒𝑑(𝑡) − 𝑉𝐵0) =
𝐸𝑠
𝐸𝑠+𝐻𝑅(𝑡)⋅𝑇𝑃𝑅(𝑡)
(𝑉𝑒𝑑(𝑡) − 𝑉𝐵0)    (2.9) 
where 𝑉𝑒𝑑(𝑡) is LV end diastolic volume (LVEDV), 𝐸𝑠 is the LV elastance, 𝐸𝐴 is 
the arterial elastance, which is also defined as the product of HR and TPR. By using the 
LV pressure-volume loop relationship and assuming blood volume in LV can represent 
the blood volume at the end of diastole state, the relationship between LVEDV, 𝑉𝑒𝑑(𝑡), 
LV end diastolic pressure (LVEDP),𝑃𝑒𝑑(𝑡), can be written as: 






𝑃𝑒𝑑(𝑡) + 1)             (2.10) 
where 𝐴 and 𝐵 are the constant parameters that define the shape of the LV pressure-
volume loop [28,29]. Besides, The relationship between the 𝑃𝐶𝑉(𝑡) in the Equation 
(2.8) and the 𝑃𝑒𝑑(𝑡) in the Equation (2.10) is proportional, which we can assume 










𝑃𝐶𝑉(𝑡) + 1)         (2.11) 
Then, by combining the Equation (2.8) and the Equation (2.11), the direct 
















𝜂𝑉𝐵0 + 1)  
(2.12) 
By multiplying the heart rate, 𝐻𝑅(𝑡) , to the Equation (2.12), the direct 
relationship between 𝑉𝐵(𝑡) and 𝐶𝑂(𝑡) yields as follows: 
𝐶𝑂(𝑡) = 𝐻𝑅(𝑡) ⋅
1
𝜃1+𝜃2𝐻𝑅(𝑡)⋅𝑇𝑃𝑅(𝑡)




where 𝜃1 = 𝐴, 𝜃2 =
𝐴
𝐸𝑠






, and 𝜃5 =  𝜂. These parameters are the 
only five constant parameters that need to be tuned individually to the measurement 
data of each specific subject. As shown in Figure 2.4, the structure of the CO sub-model 
can be visualized as a combination of LV pressure-volume loop relationship (Equation 
(2.11)) and VR system (Equation (2.6)). With the development of CO sub-model, the 
CO can be reproduced responses due to the BV change can be derived from the 






















Fig. 2.4. A sketch of the cardiac output sub-model. 
2.2.3 Modeling of Mean Arterial Pressure Response to Cardiac Output Changes 
Due to the cardiac output (CO) in the blood circulation system change, the mean 
arterial pressure (MAP) is also varied consequently. In Guyton’s previous work, the 
blood circulation system is able to regulate the blood pressure within some specific 
constant levels even patients experience hemorrhage, which variations of MAP can be 
compensated by increasing or decreasing the total peripheral resistance (TPR) via the 
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arterial autonomic-cardiac regulation [31,32]. Although the first principles nature of 
physiology mechanism are complex, the mechanism of the arterial autonomic-cardiac 
regulation can abstract into a feedback control system based on the observation of 
animal experimental dataset and the knowledge from previous study related to 
baroreflex mechanism.  
From the observation of the MAP dataset of 11 sheep, we found consistently in 
all the subjects that the arterial autonomic-cardiac regulation system brought the MAP 
back to the normal steady level in the end even the subjects experience a hemorrhage 
and their CO and BP decrease with a tremendous amount in the beginning stage. This 
phenomenon of physiological reaction is quite similar to the results from the studies of 
baroreflex system [33-35], which provides a rapid negative feedback loop in which an 
elevated blood pressure reflexively causes the heart rate to decrease and also causes 
blood pressure to decrease. Besides, since the CO sub-model in the Section 2.2.2 
incorporates the feedback information of TPR to update the CO sub-model, the MAP 
sub-model also requires the ability to implement the change of TPR and feedback the 
TPR information to the CO sub-model. Thus, by borrowing the idea from baroreflex 
system and the goal of reproducing TPR response, a TRR and MAP control-theoretic 
sub-model was established as shown in Figure 2.5. In this sub-model, the compensator 
can tune the change of TPR, Δ𝑇𝑃𝑅(𝑡), due to the difference, 𝑒(𝑡), between of the 
MAP target value and actual value, which relationship can be written as following: 
Δ𝑇𝑃𝑅(𝑡) = 𝑓(𝑒(𝑡)) = 𝑓(𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡 − 𝑀𝐴𝑃(𝑡))        (2.14) 
where 𝑓 is the transfer function of compensator that defines the relationship between 
the 𝑒(𝑡) and Δ𝑇𝑃𝑅(𝑡) , and 𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡 is a hypothetical constant parameter that 
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represents the desired value of MAP which the compensator aims to track and follow. 
For the first approach in this study, the nominal value of this target value of MAP was 
assumed to be the average of the steady-state MAP value (in the last half hour) of the 
animal experimental dataset. Furthermore, the value of MAP at time 𝑡 instant can be 
consider as the product of CO and TPR, which relationship between these three terms 
can be written as follows: 
𝑀𝐴𝑃(𝑡) = 𝐶𝑂(𝑡) ⋅ 𝑇𝑃𝑅(𝑡) = 𝐶𝑂(𝑡) ⋅ [𝑇𝑃𝑅0 + Δ𝑇𝑃𝑅(𝑡)]      (2.15) 




. For an example that can be better understood, when a subject 
experiences a hemorrhage and its CO decreases consequently, the actual value of MAP 
will drop below to the target value of MAP in the block diagram based on the Equation 
(2.15). Then, the compensator calculates the change of TPR, Δ𝑇𝑃𝑅(𝑡) , due to the 
difference between the target and actual MAP values in the Equation (2.14) (In this case, 
the Δ𝑇𝑃𝑅(𝑡) is positive due to the difference is positive). By increasing TPR, the 












Fig. 2.5. A sketch of the mean arterial pressure sub-model. 
In order to find the best compensator with less complexity and better performance 
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to represent the physiological mechanism in the real world, different type of 
compensators had been investigated and evaluated. J.T. Ottesen proposed a model for 
the human cardiovascular control system and illustrated two important parts of the 
automatic central nervous system for controlling the heart and the capillaries, which are 
the sympathetic (relatively slow-acting) and the vagal (relatively fast-acting) nervous 
systems as shown in Figure 2.6 [36,37]. There has also been other evidence presented 
that the sympathetic control of TPR (capillaries) has more contribution to the oscillation 
in blood pressure than the sympathetic feedback to the heart muscle or heart rate change 
[38,39,40]. Besides, the renin-angiotensin system also takes part in the human 
cardiovascular control system, which enable to vary the concentration of a peptide 
hormone, angiotensin, to regulate blood pressure [41]. Briefly speaking, the period of 
the cyclic oscillation in blood pressure due to the 𝛽 -sympathetic signal, which  
control the TPR (capillaries) , is similar to the period of respiration at about 3-6 seconds, 
while the cyclic oscillation in blood pressure due to the renin-angiotensin system is a 
relatively slow-acting effect, which period of oscillation is at about hours. Since the 
dynamic of baroreceptors are much faster than these two control mechanisms, we also 















Fig. 2.6. A sketch of the baroreflex cardiac control system. 
Consider the 𝛽-sympathetic nervous system as the short-term (fast) effect and 
the renin-angiotensin system as the long-term (slow) effect in the human cardiovascular 
control of TPR, we assume the transfer function, 𝐶(𝑠) , of the forward loop 






 (Type 1), where 𝑝1 and 𝑝2 represent 
the transient dynamic properties (related to time constant), and 𝑛1(∙)  and 𝑛2(∙) 
represent the nonlinear gain (sigmoid curvature defined by a parameter) of the two 
systems, and the structure of this compensator is shown in the Figure 2.7 (a). However, 
because of the limitation of sparse animal experimental dataset (5 minutes time interval), 
the fast dynamic of 𝛽 -sympathetic nervous system might not be observed in the 
identification results. Thus, we simplify the fast dynamic component as a simple 
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nonlinear gain, and the transfer function, 𝐶(𝑠), becomes 
𝑛1(∙)
𝑠+𝑝1
+ 𝑛2(∙) (Type 2), which 
can be shown in the Figure 2.7 (b). Furthermore, after we analyze the identification 
results of MAP sub-model with Type 1 and Type 2 compensator by using the CO and 
MAP data of experimental measurement, we found that the nonlinear gain of fast 




 (Type 3) as shown in the Figure 2.7 (c). Except for assuming the gains in 
compensator are nonlinear, the linear-gain cases had also been studied. We replaced the 




+ 𝑘2 (Type 4) and 
𝑘1
𝑠+𝑝1
 (Type 5) as shown in the Figure 2.7 (d) 

































Fig. 2.7. A sketch of the different type compensators. 
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After applying these five compensator to the system identification of MAP sub-
model, the fitting performances of each compensators can be quantified by calculating 
the residue sum of squares (RSS) of fitting MAP error among eleven subjects, which 
the equation of RSS is defined as follows: 
𝑅𝑆𝑆 = ∑ (𝑀𝐴𝑃(𝑡𝑖) − 𝑀𝐴?̂?(𝑡𝑖))
2𝑛
𝑖=1              (2.16) 
where 𝑀𝐴𝑃(𝑡𝑖) and 𝑀𝐴?̂?(𝑡𝑖) are the measurement value and the model prediction 
of MAP at time 𝑡𝑖, 𝑛 is the sample size of the MAP data. The fitting results of these 
five compensator are shown and compared in the Table 2.1. Besides, in order to analyze 
the accuracy-complexity trade-off between five compensators, the corrected Akaike 
information criterion (AICc) [42] of five compensators for each subjects are also 
calculated and compared subject-specifically, which value combines the fitting 
performance (RSS) and dimension of the model (number of identified parameters) and 
the equation is defined as follows: 
𝐴𝐼𝐶𝑐 = 𝑛 log (
𝑅𝑆𝑆
𝑛
) + 2𝑘 +
2𝑘(𝑘+1)
𝑛−𝑘−1
              (2.17) 
where 𝑘 is the number of identified parameters in the sub-model and 𝑅𝑆𝑆 is from the 
Equation (2.16). The AICc results of compensators are compared and shown in the 
Table 2.2. 
 
RSS Type 1 Type 2 Type 3 Type 4 Type 5 
Number of Parameters 5 4 3 3 2 
Avg. [mmHg] 36.91 36.76 37.02 37.07 37.11 




AICc Type 1 Type 2 Type 3 Type 4 Type 5 
Number of Parameters 5 4 3 3 2 
Subject 1 2.42 0.38 -3.14* 16.27 13.98 
Subject 2 30.45 26.86 24.11 23.80 21.37* 
Subject 3 -13.31 -20.46 -18.81 -21.36 -21.42* 
Subject 4 29.77 26.96 24.23 24.28 21.76* 
Subject 5 14.87 13.48 10.18 12.08 9.18* 
Subject 6 3.20 7.13 4.98 -1.11 -1.92* 
Subject 7 11.44 6.03 -2.06 -4.85 -6.46* 
Subject 8 16.51 15.39 12.84 1.54 -1.00* 
Subject 9 18.51 15.66 13.02 12.95 10.43* 
Subject 10 17.29 8.09 11.58 7.93 2.64* 
Subject 11 11.10 8.17 5.41* 8.87 6.35 
Table 2.2. AICc results of five compensators 
 
As the RSS results in Table 2.1, we can find that even we increase the number of 
parameters (complexity) in compensator, the sum of the fitting errors RSS of eleven 
subjects are still similar, which means the fitting performance cannot be improved by 
increasing its complexity of the compensator. Thus, based on the AICc results in Table 
2.2, we picked the simplest compensator, which is one-pole compensator with linear 
gain (Type 5), for the future study since it has less AICc in the 9 of 11 subjects. Besides, 
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by applying the transfer function of this compensator, 𝐶(𝑠) =
𝑘
𝑠+𝑝
 , to the 𝑓 in the 
Equation (2.14) and combining the Equation (2.15), the governing equation of the 
feedback control system of the MAP sub-model can be written as: 
𝑀𝐴𝑃(𝑡) = 𝐶𝑂(𝑡) ⋅ {𝑇𝑃𝑅0 + ℒ
−1 [𝐶(𝑠) ⋅ (
𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡
𝑠
− 𝑀𝐴𝑃(𝑠))]}  (2.18) 
With computation in the Equation (2.18), the MAP sub-model can successfully 
reproduce MAP responses and TPR responses to CO perturbation.  
 
2.3 Hemodynamic Model 
After deriving bunch of equations in the previous section, three different sub-
models are now well defined and have abilities to reproduce responses of different 
endpoints, such as blood volume (BV), stroke volume (SV), cardiac output (CO), total 
peripheral resistance (TPR) and mean arterial pressure (MAP). Besides, in each sub-
model, the ports of input and outputs are related to each other, like the output in BV 
sub-model and input in CO sub-model are both 𝑉𝐵(𝑡), and the output in CO sub-model 
and one of the input in MAP sub-model are both 𝐶𝑂(𝑡). 
Thus, for the purpose that discuss in the Chapter 1.3, which is establishing a 
simple but sufficient lumped-parameter model that can reproduce hemodynamic 
response to blood volume perturbation for the future closed-loop resuscitation 
controller design and evaluation, we combined the Equation (2.5), (2.13) and (2.18) in 
the previous sections to develop a BV-CO-MAP hemodynamic model as shown in the 
Figure 2.8. Note that the total peripheral resistance (TPR) in part (c) of the Figure 2.8 
feedbacks to the part (b) to update the TPR terms in the Equation (2.13). With this BV-
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CO-MAP hemodynamic model, the responses of BV, SV, CO, TPR and MAP can be 
reproduced with given input profile, including infusion (𝑢(𝑡)), blood loss (𝑣(𝑡)), and 









































































Chapter 3: System Identification and In-silico Evaluation 
 
3.1 Overview 
In the previous Chapter, we have presented a lumped-parameter model that can 
reproduce hemodynamic response of different endpoints to blood volume perturbation. 
In this chapter, we will further analyze and validate this model by fitting the model 
estimated blood volume (BV), cardiac output (CO), and mean arterial pressure (MAP) 
responses with the measurements collected from the eleven sheep which dataset comes 
from an animal experiment under the protocol approved by the Institutional Animal 
Care and Use Committee (IACUC) at the University of Texas Medical Branch, 
Galveston [10].  
In order to see if the model is able to be adapted to different specific subjects, we 
will perform fully individualized model identification via numerical optimization 
(subject-specific evaluation) in the following section and compare the system 
identification results with a model from previous work to see if the adaptive ability of 
the new model has been improved. After analyzing the subject-specific identified model, 
we also applied the controllers used in the animal experiment [43], including decision-
tree, PID, Fuzzy logic controllers, to the subject-specific identified model and did in-
silico closed-loop control evaluation to see if the model can reproduce similar responses 
to the experiment in different endpoints. Furthermore, we also randomized the 
parameters in the model to examine the performance of these three types of controllers 




3.2 Experimental Data 
In the experiments, all 11 animals received Lactated Ringer’s solution (LR) and 
5 of them also receive Hex solution as fluid infusion. For the 5 animals which received 
both kinds of fluids, the experiments of each fluid infusion were conducted separately 
and at least 5 days apart. The duration of the experimental study for each subject was 3 
hours. Based on the records of experiments, after the baseline data of subjects, such as 
blood volume and blood pressure in normal state, were recorded, the subject 
experienced an initial major hemorrhage, which quantity is determined based on the 
weight of subject (25ml/kg), lasting around 15 minutes. Then, fluid infusion was started 
30 minutes after the start of the major hemorrhage and continued for the rest 150 
minutes. Except for the major hemorrhage experienced in the beginning stage, there are 
also second and third relatively minor hemorrhages (both are 5ml/kg) were conducted 
20 and 40 minutes after the start of the fluid infusion, and each hemorrhage lasted for 
5 minutes. 
For the fluid infusion profile, the control input profiles of 6 subjects were 
performed automatically based on a decision-tree rule-based closed-loop controller, 
which rules were described in previous publication [10,43-44]. In the details of this 
decision-tree rule, a maximum fluid infusion was set to be 100 ml/min per 70 kg when 
mean arterial pressure (MAP) measurement values of subjects was equal to or below 
40 mmHg, 80% of the maximum fluid infusion rate was given to subjects when their 
MAP measurement values were between 41 and 44 mmHg, 60% of the maximum fluid 
infusion rate was given to subjects when their MAP measurement values were between 
45 and 49 mmHg, 30% of the maximum fluid infusion rate was given to subjects when 
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their MAP measurement values were between 50 and 69 mmHg, and 10% of the 
maximum fluid infusion rate was given to subjects when their MAP measurement 
values were between 70 and 89 mmHg. For the case that the MAP measurement values 
of subjects were equal to or above 90 mmHg, there was no fluid infusion. 
In each subject, baseline blood volume (BV) was measured by using indocyanine 
green dye (ICG) method [45]. Furthermore, the Hematocrit, which is defined as the 
ratio between the red blood cell volume (RBCV) and BV, of each subject was measured 
before and throughout the experiment with 5 minutes time-interval to measure the BV 
change at time instants. Other hemodynamic responses, including cardiac output (CO), 
heart rate (HR) and MAP, were also measured simultaneously at the same time instants. 
 
3.3 System Identification 
In this section, we will perform fully individualized model identification of the 
proposed BV-CO-MAP hemodynamic model to evaluate its ability and performance 
and determine if the model is well-conditioned. By fitting the hemodynamic responses 
of model to experimental data of subjects individually, we can investigate if the model 
is able to be adapted to the subjects and reproduce reasonable subject-specific responses 
of different endpoints. Besides, the fitting results of fully individualized models were 
also compared in terms of accuracy and accuracy-complexity trade-off with the other 
BV-CO-MAP model from our previous work (2017 version) [46]. 
3.3.1 Individualized Model Identification and Analysis 
The fully individualized system identification of BV-CO-MAP hemodynamic 
model was performed by using numerical optimization method. This model consists 
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three sub-models, and there are tunable 11 constant parameters in total: 3 in the 
Equation (2.5) (𝛼𝑢, 𝛼𝑣, 𝐾𝑝) of the BV sub-model; 5 in the Equation (2.13) (𝜃1, 𝜃2, 
𝜃3, 𝜃4, 𝜃5) of the CO sub-model; and 3 in the Equation (2.18) (𝑘, 𝑝, 𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡) of 
the MAP sub-model. The upper bound, lower bound of these 11 constant parameters 
are defined based on the study of previous literature of physiology [23-41], which are 
listed in Table 3.1, where 𝐴𝑣𝑔 is be the average of the steady-state MAP value (in the 
last half hour) of the animal experimental dataset. 
 
Parameters 𝛼𝑢 𝛼𝑣 𝐾𝑝 𝜃1 𝜃2 𝜃3 𝜃4 𝜃5 𝑘 𝑝 𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡 
Unit [∙] [∙] [∙] [𝑚𝑙−1] [mmHg∙min] [mmHg] [𝑚𝑙−1] [∙] [∙] [∙] [mmHg] 
Upper Bound 6 6 0.5 0.3 0.001 0 0.1 1 1 1 𝐴𝑣𝑔+20 
Lower Bound 0 0 0.01 0 0 -0.001 0 0.2 0 0 𝐴𝑣𝑔-20 
Table 3.1. Upper and lower bounds of the identified parameters in model 
 
After the optimization setting discussed above was defined, we give input profiles 
(including fluid infusion, hemorrhage, urine output and heart rate measurement data), 
fitting reference (including BV, CO, and MAP experimental measurement data) and a 
set of initial parameter estimates (starting point of optimization) to optimization 
problems setting and minimize the fitting error. More specifically, the optimization 
problems were solved via the optimization tools available in MATLAB Optimization 
Toolbox [47] to minimize the discrepancy between model prediction and actual 
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measurements defined as following: 















𝑀𝐴?̂?(𝑡)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅
‖
2
)  (3.1) 
where 𝜃∗ is optimum value of 𝜃 minimize the cost function in the Equation (3.1), 
𝑉?̂?(𝑡), 𝐶?̂?(𝑡), and 𝑀𝐴?̂?(𝑡) are BV, CO, and MAP experimental measurement data, 
while 𝑉𝐵(𝑡|𝜃) , 𝐶𝑂(𝑡|𝜃) , and 𝑀𝐴𝑃(𝑡|𝜃)  are the predicted BV, CO, and MAP 
response of the model with optimized parameters 𝜃∗, which simulation time step of 𝑡 
is as same as the intervals using in the dataset. 𝑉?̂?(𝑡)
̅̅ ̅̅ ̅̅ ̅, 𝐶?̂?(𝑡)̅̅ ̅̅ ̅̅ ̅̅ , and 𝑀𝐴?̂?(𝑡)̅̅ ̅̅ ̅̅ ̅̅ ̅̅  are the 
averages of each variable over the entire experiment. With these three averages, the 
error magnitudes in BV, CO, and MAP components can be normalized to the same scale.  
The optimization problem (3.1) was solved via pure (infinite-step-ahead) 
prediction. One of the fitting results, including input profile, BV, SV, CO, TPR and 
MAP fitting, of crystalloid cases (LR) are shown in Figure 3.1, and one of the fitting 
results of colloid cases (Hex) are shown in Figure 3.2. Table 3.2 shows the RMSEs 
associated with the BV-CO-MAP hemodynamic models in reproducing BV, CO, and 





Fig. 3.1. Measured versus model-predicted response to crystalloid infusion case 
 
 











1 0.09 0.19 4.75 
2 0.08 0.33 7.88 
3 0.08 0.17 3.54 
4 0.11 0.38 7.86 
5 0.11 0.42 6.20 
6 0.08 0.36 7.37 
7 0.04 0.17 4.46 
8 0.07 0.12 3.97 
9 0.19 0.27 8.83 
10 0.11 0.19 5.15 
11 0.07 0.19 7.11 
Mean (SD) 0.09 (0.04) 0.25 (0.10) 6.10 (1.81) 
(b) Colloid 
3 0.16 0.18 3.79 
4 0.06 0.12 5.97 
5 0.06 0.30 6.14 
6 0.10 0.24 6.60 
7 0.07 0.20 7.86 
Mean (SD) 0.09 (0.04) 0.21 (0.07) 6.07 (1.47) 




Subject 𝛼𝑢 𝛼𝑣 𝐾𝑝 𝜃1 𝜃2 𝜃3 𝜃4 𝜃5 𝑘 𝑝 𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡 
1 1.17 0.98 0.14 0.21 4.54e-5 -3.09e-5 0.01 0.65 0.01 0.00 91.40 
2 1.78 0.30 0.07 0.29 9.41e-5 -5.45e-6 0.02 0.41 0.02 0.06 68.45 
3 5.77 5.55 0.08 0.27 3.56e-5 -2.87e-6 0.01 0.21 0.54 0.67 82.01 
4 1.30 0.54 0.04 0.24 4.82e-4 -9.25e-10 0.10 0.46 0.01 0.02 81.11 
5 5.94 0.69 0.03 0.05 9.29e-5 -8.34e-5 0.01 0.40 0.45 0.71 61.69 
6 3.50 2.03 0.08 0.08 1.50e-4 -3.17e-7 0.01 0.31 0.01 0.00 62.36 
7 5.37 4.68 0.08 0.24 4.73e-4 -3.70e-8 0.04 0.49 0.16 0.38 62.89 
8 5.58 1.20 0.07 0.17 1.02e-4 -2.14e-6 0.01 0.49 0.01 0.02 64.11 
9 1.12 0.75 0.07 0.11 1.09e-5 -5.98e-10 0.00 0.42 0.05 0.02 69.06 
10 2.28 0.53 0.03 0.26 3.01e-5 -2.15e-5 0.01 0.41 0.16 0.73 109.24 


























3 -0.03 1.70 0.17 0.24 2.76e-4 -5.31e-5 0.02 0.23 0.40 0.59 83.21 
4 0.13 1.15 0.08 0.04 4.90e-5 -6.18e-5 0.02 0.63 0.02 0.05 77.04 
5 1.36 5.97 0.05 0.15 2.89e-4 -1.15e-6 0.02 0.38 0.02 0.10 66.35 
6 0.39 2.67 0.06 0.23 4.57e-4 -3.87e-7 0.02 0.22 0.06 0.22 75.11 

























Table 3.3. List of corresponding optimized parameters 
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3.3.2 Comparison with a Hemodynamic Model from Previous Work 
From our previous work [47], a similar BV-CO-MAP hemodynamic model was 
developed in 2017. The major discrepancies between the previous model and the model 
in this thesis are the structure of the MAP sub-model and the feedback action of total 
peripheral resistance (TPR) between the CO sub-model and the MAP sub-model. In the 
structure of MAP sub-model, while the new version was developed based on the 
feedback control theory that we mentioned in the Section 2.2.3, the previous version of 
MAP sub-model was established based on the autonomic-cardiac regulation 
phenomenon and a sigmoidal relationship between TPR and MAP [31,32]. On the other 
hand, the new version of the hemodynamic model is able to feedback and update the 
TPR term in the CO sub-model, while the previous version of CO sub-model is similar 
to the Equation (2.13) but keep TPR as a constant value without updating.  
The identification fitting results of two different models were compared as shown 
in Table 3.4, which listed the normalized BV, CO and MAP fitting error of two different 
models in both fluid (unit and percentage). As the results in Table 3.4, the new version 
BV-CO-MAP model has remarkable improvements in the CO fitting and MAP fitting. 
 
(a) Crystalloid 
 BV error [l] (%) CO error [lpm] (%) MAP error [mmHg] (%) 
Model 2017 0.10 ± 0.04 (5 ± 2%) 0.48 ± 0.21 (13 ± 4%) 8.97 ± 2.31 (12 ± 3%) 




 BV error [l] (%) CO error [lpm] (%) MAP error [mmHg] (%) 
Model 2017 0.06 ± 0.02 (3 ± 1%) 0.39 ± 0.14 (13 ± 4%) 8.04 ± 3.77 (12 ± 5%) 
Model 2018 0.09 ± 0.04 (4 ± 2%) 0.21 ± 0.07 (6 ± 1%) 6.07 ± 1.47 (8 ± 3%) 
Table 3.4. RMSEs of previous model versus recent model 
 
3.4 In-silico Closed-loop Control Evaluation 
After the identification results shows that the model is well-conditioned and 
enable to adapt to different subject in real world, we also apply the controller, which 
are identical to the ones used in experiments, to the identified model to see if the closed-
loop control system can reproduce the similar results. Besides, the performance of the 
controller, including decision-tree, PID and fuzzy logic controller, was examined by 
randomly perturb the parameters in the model and see if the controller can deal with the 
variation.  
3.4.1 Closed-loop Feedback Controllers 
Based on the closed-loop system description in the experiment [43], 6 of 11 
subjects were applied to the decision-tree controllers, 4 of 11 subjects were applied to 
the PID controllers and 1 of 11 subjects was applied to fuzzy logic controller. 
In order to make the decision-tree controllers be able to reach and maintain MAP 
at a desired level, the table of decision algorithm was defined as: (a) a maximum fluid 
infusion was set to be 100 ml/min per 70 kg when mean arterial pressure (MAP) 
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measurement values of subjects was equal to or below 40 mmHg, (b) 80% of the 
maximum fluid infusion rate was given to subjects when their MAP measurement 
values were between 41 and 44 mmHg, (c) 60% of the maximum fluid infusion rate 
was given to subjects when their MAP measurement values were between 45 and 49 
mmHg, (d) 30% of the maximum fluid infusion rate was given to subjects when their 
MAP measurement values were between 50 and 69 mmHg, (e) and 10% of the 
maximum fluid infusion rate was given to subjects when their MAP measurement 
values were between 70 and 89 mmHg. (f) For the case that the MAP measurement 
values of subjects were equal to or above 90 mmHg, there was no fluid infusion.  
For the proportional-integral-derivative (PID) controllers, the gains of the 
proportional, integral, and derivative terms are 0.025, 0.07, and 0.05. For the algorithm 
of fuzzy logic controller, it uses two linear input fuzzy sets for each of two input signals, 
which are MAP error and rate change of MAP error, four Takagi-Sugeno fuzzy control 
rules with the simplified linear rule consequents, and the centroid defuzzifier. This 
fuzzy logic controller can be considered as a nonlinear proportional-integral (PI) with 
variable gains. By changing the gains based on the two input signals, the performance 
of controller can be improved compare with the linear controllers, especially for the 
nonlinear systems. 
3.4.2 In-silico Closed-loop Control Systems Evaluation 
Except for analyzing open-loop system in the Section 3.3, which excludes the 
controller component and only uses input-output data, the closed loop control system 
was also evaluated by applying these 3 different types of controllers to the each 
identified model subject-specifically. The Figure 3.3 shows the measured versus model-
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predicted responses of closed-loop control system, and the Table 3.5 lists the 
normalized RMSEs (NRMSE) of two responses in different controller cases. 
(a) Decision-Tree Controller (Crystalloid) (b) Decision-Tree Controller (Colloid)
(c) PID Controller (d) Fuzzy Logic Controller
 
Fig. 3.3. Measured versus model-predicted responses of closed-loop control system 
 
NRMSE N BV [l] (%) CO [lpm] (%) MAP [mmHg] (%) 
DT (Crystalloid) 6 0.14 ± 0.08 (6 ± 2%) 0.79 ± 0.40 (21 ± 10%) 7.15 ± 2.47 (10 ± 3%) 
DT (Colloid) 5 0.15 ± 0.12 (7 ± 6%) 0.53 ± 0.22 (16 ± 6%) 7.32 ± 1.69 (10 ± 3%) 
PID 4 0.14 ± 0.06 (7 ± 3%) 0.51 ± 0.14 (15 ± 5%) 7.54 ± 2.07 (10 ± 2%) 
Fuzzy Logic 1 0.10 (5%) 0.48 (13%) 8.54 (11%) 
Table 3.5. NRMSEs of responses of closed-loop control system 
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3.4.3 Parameter-randomized In-silico Controller Testing 
In order to further examine the performance of each controller, we also randomly 
varied the parameters in the identified model and applied to the controller to see if the 
controller is still able to bring MAP back to normal level. Before perturbing the 
parameters, we varying one parameter at a time to justify how much range we can 
perturb of each parameter. As the results of this one-parameter perturbation, we can 
define ±15% of the nominal value is suitable range for random perturbation since all 
the parameters within this range can always reproduce reasonable responses, like MAP 
response is always within its reasonable range. One example result of each controller 
are shown in the Figure 3.4. 
(a) Decision-Tree Controller (b) PID Controller
(c) Fuzzy Logic Controller
 




The results of parameter-randomized in-silico controller testing were also 
compared with different criterion, including RMSE, NRMSE, median prediction error 
(MDPE), median absolute performance error (MDAPE), divergence (DIV), and 
Wobble [48], and all of them are list in Table 3.6. As the result, we can conclude that 





DT PID Fuzzy Logic 
RMSE [mmHg] 19.45 (1.15) 6.92 (0.41) 12.00 (0.90) 
NRMSE [∙] 0.29 (0.02) 0.09 (0.01) 0.18 (0.02) 
MDPE [∙] -2.39 (10.04) 0.36 (0.88) 0.24 (0.06)  
MDAPE [∙] 10.99 (4.62) 1.38 (0.31) 0.50 (0.13) 
DIV [∙] -0.08 (0.10) -0.08 (0.06) -0.07 (0.02) 
Wobble [∙] 6.32 (3.26) 0.86 (0.21) 0.34 (0.11) 











Chapter 4: Sensitivity Analysis 
 
4.1 Overview 
A credible mathematical model can enable controller designers to easily obtain 
insights on system behaviors and investigate the influence of each physiological 
component on the performance of closed-loop resuscitation controllers via analysis and 
simulation. Thanks to the power of computation, mathematical models can be evaluated 
in the forms of in-silico and hardware-in-the-loop test methods, which are efficient 
ways to test the closed-loop controller if their performance and robustness are sufficient 
against the wide-range clinical scenarios and the physiological variability. Besides, by 
varying the parameters in the model to generate random subjects and applying to the 
non-clinical test methods, the behavior of the controllers under different cases, 
especially the worst-case, can also be studied. Thus, based on the purpose of 
establishing validity and utility of the model, in-silico computational simulation 
incorporating mathematical models is essential for pre-clinical evaluation, which also 
reduce time and cost in controller testing compare with an animal study or experiment. 
In order to examine the validity of the BV-CO-MAP hemodynamic model to see 
if the model has the potential to contribute the design and evaluation of model-based 
closed-loop resuscitation controllers, we implemented the same controllers used in the 
animal experiments and applying them to the BV-CO-MAP model and study the 
discrepancy between in-silico simulation and experimental dataset in the previous 
chapter. However, the hemodynamic model consists 11 parameters, which dimension 
is too high and costs a lot of computation. Besides, based on the characteristics of 
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physiological-based model and the identification results in previous section, we think 
some of parameters might depend on each other, which means the model might has 
over-fitting issue and the variabilities of some group of parameters can eliminated. Thus, 
parametric sensitivity analysis will also be applied in order to determine high-
sensitivity parameters (have a large contribution on the model outputs) and low-
sensitivity parameters (have a small contribution on the model outputs). With the 
sensitivity results, we can further understand the identifiability properties of the model 
and obtain a lower dimension model by fixing identified low-sensitivity parameters in 
the model at some certain nominal values to save the computation cost and solve 
potential over-fitting issue. 
After the sensitivity of each parameter had been ranked, we only varied the high-
sensitivity parameters to generate random subjects, which the distributions of 
parameters are based on the identification results and then applied to the controller to 
do further in-silico controller testing. 
 
4.2 Parametric Sensitivity Analysis 
The computational hemodynamic model provides important insights into the 
underlying mechanism of function of circulatory. However, the parameter estimation in 
the model might be a challenge due to possibility of model being over-parameterized. 
Thus, sensitivity analysis also presents a key tool for exploring the identifiability of 
parameters in the model, which order of parameters is the same as we use in 
identification section as following: 
𝑋 = {𝛼𝑢, 𝛼𝑣, 𝐾𝑝, 𝜃1, 𝜃2, 𝜃3, 𝜃4, 𝜃5, 𝑘, 𝑝, 𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡} 
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In this section, local and global sensitivity analyses were performed on the BV-
CO-MAP hemodynamic model to determine the relative importance of each parameter 
or groups of parameters. The goal of this section is to fix identified low-sensitivity 
parameters at their nominal values and obtain a well-conditioned model which can 
reduce the issue of over-fitting. 
4.2.1 Local Sensitivity Analysis 
The ‘local’ sensitivity analysis (LSA) is the type of sensitivity analysis that can 
only address the sensitivity relative to the chosen parameter sets and not for the entire 
feasible parameter space [49]. Since practical reasons that the model in this thesis is 
complex and hard to apply the differential sensitivity analysis, the one-at-a-time (OAT) 
method was applied to the LSA of this model, which is the simplest method that 
repeatedly varies one parameter at a time while holding the others fixed at their nominal 
values [50]. With this sensitivity analysis method, a sensitivity ranking can be obtained 
rapidly by varying a parameter by some given percentage while leaving all other 
parameters constant and then qualifying the contribution of each parameter in model 
output. 
With using the subject-specific optimum of each optimization as the reference 
point of parameter set we want to estimate, we varied the parameters by -20%, -15%, -
10%, -5%, 5%, 10%, 15%, and 20% with OAT method and monitored the changes in 














































From the LSA results of all 11 subjects, we can note that the four parameters in 
the CO sub-model (𝑋4,5,7,8), which are {𝜃1, 𝜃2, 𝜃4, 𝜃5}, have high sensitivity compare 
to the rest of parameters, especially the 𝑋7 and 𝑋8 (𝜃4 and 𝜃5) are high sensitivity 
parameters in all 11 LSA results of subjects. 
4.2.2 Global Sensitivity Analysis 
Despite the simplicity of OAT local sensitivity method however, this approach 
did not fully explore the input parameter space. Besides, since this method did not vary 
input parameters simultaneously, the OAT approach also cannot detect the effects of 
interaction between input variables. Thus, based on these reasons, the ‘global’ 
sensitivity analysis (GSA) was also performed to the BV-CO-MAP hemodynamic 
model. 
The GSA explores parameter space so that it provides robust sensitivity measures 
in the presence of nonlinearity and interactions among the parameters in the model [51]. 
While the OAT method mentioned in previous section is different-based, one of the 
most popular GSA forms called Sobol’ method is based on decomposition of the model 
output variance into the summands of variances of the input parameters in increasing 
dimensionality [52]. Sobol sensitivity analysis (SSA) determines the contribution of 
each input variable and their interactions to the overall model output variance. Thus, 
SSA is used to identify key parameters whose uncertainty most affects the variation of 
the model output of interest, especially for the models that are nonlinear and complex. 
However, most models in reality are involving inequality constraints, such as 
some parameters in the model are dependent, which implies that the shape of the 
parameter space may no longer be hyper-rectangle, which the shape is only determined 
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by the upper and lower bounds of each parameter. In the BV-CO-MAP hemodynamic 
model, we imposed minimum and maximum thresholds for the model output since BV, 
CO and MAP should vary in reasonable ranges, which can be defined as inequality 
constraints. Thus, because the SSA problem in the thesis is defined in a non-rectangular 
domain, the acceptance-rejection sampling method (ARS) is implied to the SSA to deal 
with non-rectangular parameter space problem [53]. By replacing the probability 
distribution function (pdf) in the calculation of model output variance, the Sobol indices 
can be transformed to the parameter space with any shape or disconnected cases. After 
the Sobol indices are calculated, we can rank the eleven parameters to find out which 
parameters are important for different states. 
As shown in Figure 4.2, the joint pdf, 𝑝(𝑦, 𝑧), where 𝑦 is the arbitrary subset of 
variables, 𝑧  is the complementary subset of variables, and (𝑦, 𝑧)  is the whole 
parameter set input of the model, is in the absence of constrain in a rectangle domain, 
𝐻𝑛 , where 𝑛 is the number of dimensions. By assuming that the constraining the 
variables to an area Ω𝑛 ⊂ 𝐻𝑛 and labeling the points inside the Ω𝑛 as 1, while the 
points outside the Ω𝑛 as 0, the 𝐼Ω(𝑦, 𝑧) can be defined as follows: 
𝐼Ω(𝑦, 𝑧) = {
1,      (𝑦, 𝑧) ∈ Ω𝑛
0,      (𝑦, 𝑧) ∉ Ω𝑛
                  (4.1) 
With similar setting mentioned above, we can also implies that the modified joint 
pdf, 𝑝Ω(𝑦, 𝑧), which takes zero values in the region outside of Ω𝑛, is proportional to 
𝑝(𝑦, 𝑧) within Ω𝑛, and can be written as: 
𝑝Ω(𝑦, 𝑧) = {
𝑝(𝑦,𝑧)
𝐼̅
, (𝑦, 𝑧) ∈ Ω𝑛
0,    (𝑦, 𝑧) ∉ Ω𝑛
                   (4.2) 
where 𝐼 ̅ is a scaling factor that represents the ratio of volume between Ω𝑛 and 𝐻𝑛, 
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∑ 𝐼Ω(𝑦𝑖 , 𝑧𝑖)
𝑁
𝑖=1                       (4.3) 
where 𝑁 is total sample size for calculating the sensitivity, and the accuracy of 𝐼 ̅ can 
be increased by increasing 𝑁. 
 
Fig. 4.2. Domain Ω𝑛 ⊂ 𝐻𝑛 [54] 
With modifying Monte Carlo (MC) numerical estimator [54] in the original SSA 
method and applying 𝐼Ω(𝑦𝑖 , 𝑧𝑖) from the Equation (4.1), the expect value, 𝑓0 , and 
total variance, 𝐷, of the model output are computed using the modified MC estimators, 




∑ 𝑓(𝑦𝑖 , 𝑧𝑖)𝐼
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𝑁




∑ [𝑓(𝑦𝑖 , 𝑧𝑖) − 𝑓0]
2𝐼Ω(𝑦𝑖 , 𝑧𝑖)
𝑁
𝑖=1                (4.5) 
where 𝑓(𝑦𝑖 , 𝑧𝑖) is the model output with the input variables (𝑦𝑖 , 𝑧𝑖).  
In order to calculate Sobol sensitivity indices, the constrained marginal pdf needs 
to be defined before the calculation, which represents the pdf that only varying group 








𝑘=1                   (4.6) 
where 𝑁𝑧 is sample size for calculating the constrained marginal pdf.  
For the Sobol sensitivity indices, there are two different indices to represent the 
sensitivity of the parameters in the model. One of the indices is the main effect index 
of the subset 𝑦, 𝑆𝑦, which represents the first order sensitivity of the subset 𝑦. The 
other index is the total effect index of the subset 𝑦, 𝑆𝑦
𝑇, which represents the interaction 
between the subset 𝑦 and the other parameters. Besides, based on the knowledge of 
Sobol indices [52], we also know that the main effect index of the subset 𝑦, 𝑆𝑦, and 
the total effect index of the subset 𝑧  (complementary subset), 𝑆𝑧
𝑇 , cover all the 
contribution of the model output. Thus, the relationship between 𝑆𝑦 and 𝑆𝑧
𝑇 can be 
defined as: 
𝑆𝑦 + 𝑆𝑧
𝑇 = 1                         (4.7) 
For the ARS method, we can apply the values from the Equation (4.3), (4.4), (4.5) 
and (4.6) to the equation of the total effect index of the subset 𝑧, 𝑆𝑧






∑ [[𝑓(𝑦𝑙 , 𝑧𝑙)𝐼




]𝑁𝑙=1    (4.8) 
where the subset 𝑧 with notation, 𝑧𝑙′, is another random complementary parameters 
subset generated from the (𝑦, 𝑧), which fixes 𝑦 and varies 𝑧 randomly. 
Because we know that the relationship between 𝑆𝑦 and 𝑆𝑧
𝑇 in the Equation (4.7), 
the 𝑆𝑦 can be derived by plugging in the 𝑆𝑧
𝑇 from the Equation (4.8) to the Equation 
(4.7), which 𝑆𝑦 can be expanded as: 
𝑆𝑦 = 1 −
1
2𝐷𝑁𝐼2̅
∑ [[𝑓(𝑦𝑙 , 𝑧𝑙)𝐼




]𝑁𝑙=1  (4.9) 
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By monitoring the changes of output at different time instants (5 minutes time 
interval is applied) and using their value to calculate 𝑆𝑦 of corresponded time instants, 
we can examining the time evolution of parametric sensitivity functions, which offers 
additional insights as to the relative importance and identifiability properties of the 
parameters in the model. 
The sensitivity of 11 parameters in BV, CO, MAP responses of different timeline 
are ranked and shown in Figure 4.3, which higher value indicates higher ranking (11 in 
(b) represents highest rank). As the CO and MAP results of Sobol analysis, which 
contain the contribution from all 11 parameters, we can note that the three parameters 
in the CO sub-model and one in the MAP sub-model (𝑋4,7,8,9), which are {𝜃1, 𝜃4, 𝜃5, 𝑘}, 
have high sensitivity compare to the rest of parameters, especially the 𝑋7 (𝜃4) are high 








Fig. 4.3. Global sensitivity ranking 
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Chapter 5: Conclusion and Future Work 
 
5.1 Discussion 
In this thesis, we have developed a control-theoretic model that can reproduce 
hemodynamic responses of desired endpoints in clinical practice to fluid infusion or 
hemorrhage, such as blood volume (BV), stroke volume (SV), cardiac output (CO), 
total peripheral resistant (TPR), and mean arterial pressure (MAP). Because of the 
simplicity, the proposed model can become a viable basis for closed-loop resuscitation 
controller design and evaluation. Besides, the physiological transparency of the 
proposed model allow credible validation and implementation for controller designer. 
The accuracy and properties of this proposed model are further discussed specifically 
in following.  
From the results of system identification (Chapter 3), the model accuracy can be 
determined in terms of the fitting error between measured and model-predicted values. 
By varying 11 degree of freedom in the model, it can accurately reproduce the 
hemodynamic responses with individual animals in both crystalloid (LR) and colloid 
(Hex) fluid infusion cases. Across the open-loop identification (only using input-output 
data) of all 11 animals, the RMSEs associated with BV, CO, and MAP were 0.09 ± 0.04 
L (crystalloid) and 0.09 ± 0.04 L (colloid), 0.25 ± 0.10 Lpm (crystalloid) and 0.21 ± 
0.07 Lpm (colloid), 6.10 ± 1.81 mmHg (crystalloid) and 6.07 ± 1.47 mmHg (colloid), 
respectively (Table 3.2). Comparing the results with previous version of hemodynamic 
model, the goodness of current version is that MAP sub-model can reproduce the TPR 
term and feedback to CO sub-model in order to give us insight of how blood vessel 
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muscles change in cardiac regulation system, which also enhance the physiological 
transparency, and perform better fitting which can be observed in the CO and MAP 
responses. Besides, after we applied different experimental-used controllers and 
consider closed-loop control system, the system can also reproduce similar results to 
the experimental data. Overall, the proposed model exhibited remarkable performance 
in reproducing hemodynamic responses its simple model structure, which might offer 
a more viable basis in the field of model-based controller design than complex first-
principles models. 
For the parametric sensitivity discussed in the Chapter 4, the time evolution of 
the parametric sensitivity provide further insights of the relative importance and 
identifiability of the model parameters. Although the controller had been examined in 
the randomize all 11 parameters in the model with certain range, the model still need 
sensitivity analysis to find out if there is a group of parameters which are dependent to 
each other and the rule of generating random subjects should be based on this result. 
From the rankings of the parameters in both local and global sensitivity analysis, while 
some parameters has similar ranking pattern in both method (High sensitivity: 𝜃1, 𝜃4 
and 𝜃5 ; Low sensitivity: 𝜃2  and 𝑝 ), other rankings of parameters produce more 
distinct pattern. This observation might occurs because (a) local sensitivity is a subject-
specific analysis that parametric sensitivity is restricted with certain region in parameter 
space or (b) the acceptance-rejection sampling method decrease the accuracy of global 
sensitivity (Sobol), which needs much more model samples to investigate all the 
parameter space. Despite the parameters with distinction, the other parameters with 
similarity in both methods can be conclude that they have high (low) sensitivity in all 
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feasible domain of parameter space, which we can fix the low sensitivity parameters 
and vary other parameters, especially high sensitivity parameters, to generate random 
subjects. 
 
5.2 Future Work 
There are some aspects of the model can be potentially improved in future to 
make the proposed model more amenable to the closed-loop fluid resuscitation 
controller design and evaluation. Since parametric sensitivity analysis of both methods 
are not identical, the parametric sensitivity should be further studied by calculating 
correlation coefficients of each parameter as well as increase the sampling number in 
Sobol analysis to enhance accuracy. Besides, after the parameters have been ranked and 
fixed the low-sensitivity parameters as their nominal value, the model with lower 
dimensions should re-identified to fit the dataset and see if the partial parameters 
(exclude low-sensitivity parameter) can make the model still adapt to all specific 
subjects. Then in-silico closed-loop controller testing can be also applied to this 
partially individualized model in order to obtain a better-conditioned model which can 
deal with issues in clinical practice, such as physiologically variability and challenging 
clinical scenarios, with higher efficiency. 
 For the model structure standpoint, the current model for the controller 
evaluation is assumed that the heart rate (HR) and urine output (UO) information is 
available as input to the model. However, the heart rate and urine measurements in 
some clinical cases might not be available, and an ideal model should generate all the 
desired responses itself. Thus, the heart rate component of baroreflex system and kidney 
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function for urine output will be incorporated in future hemodynamic model, which 
mechanism of HR might be similar to the mechanism of changing TPR in the MAP 
sub-model. In addition, the unstressed blood volume in the current model is set to be a 
constant, while the regulation of unstressed blood volume might be also an important 
component in hemodynamic responses to blood volume perturbation [55]. Based on 
these ideas, the expansion of the updated model may potentially facilitate the creation 
of physiological models suited to design and evaluation of closed-loop controllers in 
the field of physiological system. 
 
5.3 Conclusion 
The proposed control-theoretic hemodynamic model was developed and analyzed 
with experiment dataset, which results show that the model can be beneficial for the 
design and evaluation of closed-loop feedback fluid resuscitation system in critically ill 
patients. The proposed model was equipped with several characteristics, including 
structural simplicity, physiological transparency, and predicted accuracy, which are 
essential for in-silico testing and model-based pre-clinical evaluation. As the result, a 
wide range of clinical scenarios can be evaluated via rigorous in-silico testing methods, 
especially the worst case of closed-loop fluid resuscitation controllers’ behavior. 
Besides, since all the analysis and evaluation can be done within computational 
programming, the in-silico simulations incorporating credible models potentially 
reduce time and cost of controller design compare with the large-scale animal study. 
Ultimately, the efforts we made into investigating and improving the hemodynamic 
model so far is impactful to the autonomous fluid resuscitation and critical care 
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